Clinical trial

Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in…

NCT00393198 · Bayer, Industry · Completed

Key facts

NCT number NCT00393198
Title Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
Official title Multicenter Study to Investigate the Bleeding Profile and the Insertion Easiness in Women Inserted With a Second Consecutive MIRENA for Contraception or Menorrhagia
Lead sponsor Bayer, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Contraception, Menorrhagia
Intervention type Drug
Interventions Levonorgestrel (Mirena, BAY86-5028), Cytotec, Placebo
Enrollment 204
Start date Oct 1, 2006
Primary completion Oct 1, 2012
Completion Oct 1, 2012
First posted Oct 27, 2006
Last update posted Nov 3, 2014
Countries Finland, France, Ireland, Sweden

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies